An international multicentre, randomized, parallel group, double-blind trial to evaluate different dose combinations of lercanidipine and enalapril in comparison with each component administered alone and with placebo in patients with essential hypertension.
- Registry ID
- EUCTR2009-015988-13
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- Recordati S.p.A.,
- Start date
- 2010-01-02
- Last update
- 2026-08-16
Conditions
- Essential hypertension
- Hipertensión esencial. Essential hypertension
Summary
The primary objective of this study is to evaluate the optimal dose combinations of lercanidipine and enalapril as initial treatment of patients with moderate essential hypertension.
Locations
- , , Italy
- , , Germany
- , , France
- , , Poland
- , , Spain
View on source registry